<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.api.service.company.analytics.soap.ct.v1.DrugRecordOutput xmlns:ns2="local" id="12533"><DrugName>NTE-122</DrugName><DrugSynonyms><Name><Value>NTE-122</Value><Types><Type>Research Code</Type></Types></Name><Name><Value>ACAT inhibitor, Nissin Food</Value></Name><Name><Value>166967-85-7</Value><Types><Type>CAS RN</Type></Types></Name></DrugSynonyms><CompanyOriginator id="18569">Nissin Foods Holdings Co Ltd</CompanyOriginator><CompaniesSecondary><Company id="18569">Nissin Foods Holdings Co Ltd</Company></CompaniesSecondary><CrossReferences><SourceEntity id="12533" type="Drug"><TargetEntity id="226288" type="siDrug">NTE-122</TargetEntity></SourceEntity><SourceEntity id="18569" type="Company"><TargetEntity id="4295876922" type="organizationId">Nissin Foods Holdings Co Ltd</TargetEntity></SourceEntity><SourceEntity id="33" type="ciIndication"><TargetEntity id="I70" type="ICD10"></TargetEntity><TargetEntity id="440" type="ICD9"></TargetEntity><TargetEntity id="D050197" type="MeSH"></TargetEntity><TargetEntity id="-848966698" type="omicsDisease"></TargetEntity><TargetEntity id="208" type="siCondition"></TargetEntity></SourceEntity><SourceEntity id="17" type="Action"><TargetEntity id="809" type="Mechanism">Acetyl-CoA Thiolase Inhibitors</TargetEntity><TargetEntity id="380" type="Mechanism">ACAT Inhibitors</TargetEntity></SourceEntity><SourceEntity id="71" type="Action"><TargetEntity id="693" type="Mechanism">Cholesterol Absorption Inhibitors</TargetEntity></SourceEntity></CrossReferences><PhaseHighest id="DX">Discontinued</PhaseHighest><PhaseTerminated id="DR">Discovery</PhaseTerminated><IndicationsSecondary><Indication id="33">Atherosclerosis</Indication></IndicationsSecondary><ActionsPrimary><Action id="17">ACAT inhibitor</Action></ActionsPrimary><ActionsSecondary><Action id="71">Antihypercholesterolemic agent</Action></ActionsSecondary><Technologies><Technology id="762">Small molecule therapeutic</Technology></Technologies><EphmraCodes><Ephmra><Code>C10A</Code><Name>CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS</Name></Ephmra></EphmraCodes><LastModificationDate>2017-08-18T05:42:00.000Z</LastModificationDate><ChangeDateLast>2003-05-23T16:05:24.000Z</ChangeDateLast><AddedDate>1996-06-11T10:50:09.000Z</AddedDate><DevelopmentProfile><Summary><displayLabel>Summary</displayLabel><value>&lt;Summary&gt;&lt;para&gt;Nissin was evaluating &lt;ulink linkID="12533" linkType="Drug"&gt;NTE-122&lt;/ulink&gt; as a potential anti-arteriosclerotic agent [&lt;ulink linkID="210044" linkType="reference"&gt;210044&lt;/ulink&gt;]. However, the project was discontinued following the company's decision to terminate all pharmaceutical research activities in 1999 [&lt;ulink linkID="422129" linkType="reference"&gt;422129&lt;/ulink&gt;].&lt;/para&gt;&lt;para&gt;The compound acts as an ACAT inhibitor by preventing the accumulation of cholesterol in vascular walls. Preclinical data had demonstrated cholesterol reduction in various animal models of hyperlipidemia and inhibition of spontaneous-onset arteriosclerosis in rabbits. The drug was expected to enter clinical trials in 1997 [&lt;ulink linkID="210044" linkType="reference"&gt;210044&lt;/ulink&gt;].&lt;/para&gt;&lt;/Summary&gt;</value></Summary></DevelopmentProfile><IDdbDevelopmentStatus><DevelopmentStatusCurrent><Company id="18569">Nissin Foods Holdings Co Ltd</Company><Country id="JP">Japan</Country><DevelopmentStatus id="DX" sortOrder="4">Discontinued</DevelopmentStatus><DiscontinuedReason id="5">Other</DiscontinuedReason><Indication id="33">Atherosclerosis</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v1.ct.soap.analytics.company.service.api.ls.thomsonreuters.com/">2001-09-12T00:00:00.000Z</StatusDate><Source id="422129" type="CORPORATE"></Source></DevelopmentStatusCurrent><DevelopmentStatusHistoric><Company id="18569">Nissin Foods Holdings Co Ltd</Company><Country id="JP">Japan</Country><DevelopmentStatus id="DR" sortOrder="7">Discovery</DevelopmentStatus><Indication id="33">Atherosclerosis</Indication><StatusDate xmlns:ns3="http://serviceversion" xmlns:ns2="http://v1.ct.soap.analytics.company.service.api.ls.thomsonreuters.com/">1996-06-11T00:00:00.000Z</StatusDate><Source id="210044" type="SERIAL"></Source></DevelopmentStatusHistoric></IDdbDevelopmentStatus><Targets><Target id="PTGT-00038"><Name>ACAT</Name><SwissprotNumbers></SwissprotNumbers></Target></Targets><ReasonsForUpdate><ReasonForUpdate><Reason>Development Status Updated</Reason><Description>One or more development status entries have been updated</Description></ReasonForUpdate></ReasonsForUpdate><StructureSmiles><Smiles>CN(c1ccc(cc1)NC(=O)N(C2CCCCC2)C[C@H]3CC[C@@H](CC3)CN(C(=O)Nc4ccc(cc4)N(C)C)C5CCCCC5)C</Smiles></StructureSmiles><hasSWOTs>N</hasSWOTs></ns2:com.thomsonreuters.ls.api.service.company.analytics.soap.ct.v1.DrugRecordOutput>